BARD1 and cancer: Speculating on the relationship between miR-19a/b expression levels and leukemogenesis, we hypothesized that lower levels of miR-19a/b could be related to cancer advancement, whereas higher expression, coupled with overexpression of BARD1 oncogenic isoforms, may provide a better response to Vorinostat treatment by altering the ceRNA code.